Clinical features of malignant hypertension with thrombotic microangiopathy. - Wikidata - awgldk - TriplyDB

Clinical features of malignant hypertension with thrombotic microangiopathy.

Clinical features of malignant hypertension with thrombotic microangiopathy.

http://www.wikidata.org/entity/Q33393559

about

A case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertension Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI).Malignant Hypertension and Thrombotic Thrombocytopenic Purpura: False Friends.Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.The global aHUS registry: methodology and initial patient characteristics.Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study Hypertensive Urgencies and Emergencies in the Hospital Setting.Malignant Hypertension Revisited-Does This Still Exist?Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Relationships between edema degree and clinical and biochemical parameters in posterior reversible encephalopathy syndrome: a preliminary study.Thrombotic Microangiopathy and the Kidney.

P2860

Q33406143-6EF0001F-2E34-4FF9-8A2F-7C38E90D76F5 Q33419321-FEE63758-E11D-49B1-806D-A4AFB9AE0418 Q33423695-6A9D29C0-DE93-44F4-974F-B63656207D13 Q33424106-6C3C863C-8B7C-4703-B717-F0F7EE0FB4D4 Q33428291-9486A601-E2DA-408C-B197-6B24CED25028 Q33705135-1569E425-A85C-4669-9933-F9CF864CBC03 Q35986230-80BF1D53-6C54-444F-A61B-CB4F2F344157 Q38701950-DA6DCCCA-36FC-4E39-A2A1-96020F8B3C4E Q39136798-DE8324EE-5123-426A-978D-94C4CB8F5E45 Q42086661-D893B37E-9CB9-447C-A2F9-B9419306F9E9 Q48596417-07B7A16A-EC00-4532-A0A7-D1BEE85EADF2 Q50085453-267BF838-8ED3-4546-BC80-7C76CE415653

P2860

Clinical features of malignant hypertension with thrombotic microangiopathy.

http://www.wikidata.org/entity/Q33393559

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical features of malignant hypertension with thrombotic microangiopathy.

@ast

Clinical features of malignant hypertension with thrombotic microangiopathy.

@en

type

label

Clinical features of malignant hypertension with thrombotic microangiopathy.

@ast

Clinical features of malignant hypertension with thrombotic microangiopathy.

@en

prefLabel

Clinical features of malignant hypertension with thrombotic microangiopathy.

@ast

Clinical features of malignant hypertension with thrombotic microangiopathy.

@en

P1433

Q33393559-7DB5F24B-0679-40D2-8109-F11F49D56510

P1476

Q33393559-886E5FF3-251E-4284-95EF-9A9EAB439AF9

P2093

Q33393559-03AB3423-D2EE-4140-9ED5-C51190F991B8

Q33393559-6E1F0A38-7511-4091-8913-FB1BF47CF187

Q33393559-A5081C11-ECC1-47D7-8FE6-0F7A6C29ACF8

Q33393559-B99C1209-11BC-4F07-B90A-7787AF978DFE

Q33393559-C65189BC-BCD6-4B36-B2DE-C9F9AB01E0D2

Q33393559-D2C58FC8-F602-4EA9-9B3D-15EE249B6DC2

Q33393559-F5873900-9AFF-4B8D-9A05-BACE8D28E950

P2860

Q33393559-0644CEA3-FE5A-4F49-87E9-9407AA84189D

Q33393559-25437237-83B2-4CBC-AB70-1016EF7C561E

Q33393559-30A9F6E7-0499-480E-AA4A-3D97AF7BF2ED

Q33393559-32018A3D-776C-4E61-BE6E-2F8025E444C1

Q33393559-46B484B6-0EC8-4731-BED3-88DA9ECA41FC

Q33393559-4D85B12F-CB8D-4910-8086-C17A8D4F10B6

Q33393559-5AEDA60C-01BE-4E0F-80E3-158B9562632A

Q33393559-5E31A37B-B47F-45C6-B045-9D739DC76506

Q33393559-60B45FEC-57E0-4E97-BF32-B53ADCA53C98

Q33393559-6A15116B-3807-4966-9729-B0BC9CEC12C9

P304

Q33393559-5E96A023-56DE-4590-AA59-6E7E372ABA05

P31

Q33393559-3126DFFA-F111-4092-B003-E925495BD3D0

P356

Q33393559-6EF44265-0BCE-4CB3-A9AF-47F7DA652A71

P433

Q33393559-76DAB072-E624-47AA-B78E-3C6C9139D4E2

P478

Q33393559-F9BE1570-E056-4487-A3AA-7A402A3D84AD

P577

Q33393559-21D003D0-8327-484E-8015-8694ECDADFD6

P698

Q33393559-7ECCD4E9-BD70-4736-865F-92E1E31DA6CA

P356

10641963.2010.503303

P1433

Clinical and Experimental Hypertension

P1476

Clinical features of malignant hypertension with thrombotic microangiopathy

@en

P2093

Chiharu Ito

http://www.w3.org/2001/XMLSchema#string

Eiji Kusano

http://www.w3.org/2001/XMLSchema#string

Hideaki Takahashi

http://www.w3.org/2001/XMLSchema#string

Shigeaki Muto

http://www.w3.org/2001/XMLSchema#string

Shinichi Takeda

http://www.w3.org/2001/XMLSchema#string

Tetsu Akimoto

http://www.w3.org/2001/XMLSchema#string

Yukio Ando

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?

Renal involvement in patients with thrombotic thrombocytopenic purpura.

Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura.

Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.

A decreased metabolic clearance rate of aldosterone in benign essential hypertension.

Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension

Aldosterone and the vascular system.

Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.

Influence of nicardipine on blood pressure, renal function and plasma aldosterone in normotensive volunteers.

Comparison of intravenous nitroprusside, nitroprusside-captopril, and nitroglycerin for deliberate hypotension during posterior spine fusion in adults.

P304

77-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10641963.2010.503303

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21214403

http://www.w3.org/2001/XMLSchema#string